StrykerUS8636671013SYKSYK
Financials
Market Cap
$128.16B5Y beta
0.92EPS (TTM)
$8.248Free Float
359.95MP/E ratio (TTM)
40.84Revenue (TTM)
$20.50BEBITDA (TTM)
$5.37BFree Cashflow (TTM)
$2.00BPricing
Analyst Ratings
The price target is $370.96 and the stock is covered by 28 analysts.
Buy
18
Hold
10
Sell
0
Information
Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. The Company operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Stryker is also engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Stryker's geographical segments include the United States and the International.